Skip to content
Screener

LeMaitre Vascular LMAT Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Medtronic logo
MedtronicMDT
MiMedx Group logo
MiMedx GroupMDXG
AngioDynamics logo
AngioDynamicsANGO

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.86B-11.4%
Enterprise value$1.85B-11.3%
P/E28.3×-16.2×
P/S7.1×-1.9×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line itemFor the six months ended / June 30, 2026For the six months ended / June 30, 2025
Amortization of issuance costs on convertible senior notes446433
Non-cash investment income(805)
Provision for inventory write-downs1,5481,030
Provision for credit losses333337
Foreign currency transaction effect on income145(279)
Changes in operating assets and liabilities:
Accounts receivable(2,877)(5,299)
Inventory and other deferred costs(1,935)(3,454)

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's accounts receivable, credit loss expense (reversal)?
LeMaitre Vascular (LMAT) reported accounts receivable, credit loss expense (reversal) of $333K in Q2 2026.
How has LeMaitre Vascular's accounts receivable, credit loss expense (reversal) changed year-over-year?
LeMaitre Vascular's accounts receivable, credit loss expense (reversal) increased by 2.5% year-over-year, from $325K to $333K.
What is the long-term trend for LeMaitre Vascular's accounts receivable, credit loss expense (reversal)?
Over 3 years (2022 to 2025), LeMaitre Vascular's accounts receivable, credit loss expense (reversal) has grown at a 8.6% compound annual growth rate (CAGR), from $637K to $817K.
What does accounts receivable, credit loss expense (reversal) mean?
Accounts Receivable, Credit Loss Expense (Reversal)

Ask your AI about LeMaitre Vascular's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude